Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials.

Abstract

AIMS Current recommendations on the use of bivalirudin in patients treated with percutaneous coronary intervention (PCI) are mostly based on trials comparing bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibitor (GPI). Whether bivalirudin is also superior to heparin alone is still not well established. This meta-analysis investigates the… (More)
DOI: 10.4244/EIJY14M08_01

Topics

Cite this paper

@article{Cassese2015BivalirudinVH, title={Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials.}, author={Salvatore Cassese and Robert Byrne and Karl-Ludwig Laugwitz and Heribert Schunkert and Peter B. Berger and Adnan Kastrati}, journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology}, year={2015}, volume={11 2}, pages={196-203} }